
Dr. Mark K Buyyounouski M.D.
Radiation Oncologist | Radiation Oncology
333 Cottman Ave Fox Chase Cancer Cen Philadelphia PA, 19111About
Dr. Mark Buyyounouski practices Radiation Oncology in Philadelphia, PA. Radiation oncology is a medical specialty that involves treating cancer with radiation. Dr. Buyyounouski specializes in treating cancer with radiation, using radiation therapy to treat a wide variety of cancers. Radiation therapy uses carefully targeted and regulated doses of high-energy radiation to kill cancer cells.
Education and Training
Umdnj-New Jersey Med Sch- Newark Nj 2000
UMDNJ - NJMS 2000
Board Certification
RadiologyAmerican Board of RadiologyABR- 2006
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial.
- Radiation dose and late failures in prostate cancer.
- The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancer.
- What dose of external-beam radiation is high enough for prostate cancer?
- Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate.
- Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy.
- Percentage of biopsy cores positive for malignancy and biochemical failure following prostate cancer radiotherapy in 3,264 men: statistical significance without predictive performance.
- How can men destined for biochemical failure after androgen deprivation and radiotherapy be identified earlier?
- Does transurethral resection of prostate (TURP) affect outcome in patients who subsequently develop prostate cancer?
- Does treatment duration affect outcome after radiotherapy for prostate cancer?
- Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
- Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.
- Evaluation of the Prostate Cancer Prevention Trial Risk calculator in a high-risk
- Surveillance for stage I seminoma: better the devil you know than the devil you don't?
- Gains from real-time tracking of prostate motion during external beam radiation therapy.
Publications
- Jourl of clinical oncologyRandomized trial of hypofractioted exterl-beam radiotherapy for prostate cancer.2013
- JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKGleason Scoring at a Comprehensive Cancer Center: What's The Difference?2013
- JOURL OF CLINICAL ONCOLOGYValidating the Interval to Biochemical Failure2012
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSRADIOTHERAPY DOSES OF 80 GY AND HIGHER ARE ASSOCIATED WITH LOWER MORTALITY IN MEN WITH GLEASON2012
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSDEVELOPMENT OF RTOG CONSENSUS GUIDELINES FOR THE DEFINITION OF THE CLINICAL TARGET VOLUME FOR2010
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSInflammatory Bowel Disease Is Not an Absolute Contraindication to Definitive Radiation Therapy2013
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSCT-MRI Fusion Uncertainty in Prostate Treatment Planning for Different Image Guidance Techniques2013
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSToxicity and Biochemical Failure Following Image2013
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSImproved Outcomes in Men Treated With Adjuvant2013
- TURE REVIEWS UROLOGYStratifying intermediate-risk patients for radiotherapy2013
- PHYSICS IN MEDICINE AND BIOLOGYReduction of prostate intrafractiol motion from shortening the treatment time2013
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSA Novel Method for Predicting Late Genitouriry Toxicity After Prostate Radiation Therapy2013
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSUntitled Reply2013
- Intertiol jourl of radiation oncology, biology, physicsIn reply to Cheung.2013
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSProspective Validation of Diagnostic Tumor Tissue Ki2012
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPrimary Prostate Radiation Therapy: Where Are We Failing?2012
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSDetermints of Prostate Biopsy Positivity 2 Years After Radiation Therapy2012
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSDo Testosterone Kinetics After Radiation Therapy (RT) Predict Biochemical Failure (BCF) for Low-2012
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSRecursive Partitioning Alysis of Intermediate Risk Prostate Cancer Patients Identifies Subgroup2012
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSA Novel Methodology to Predict Late Uriry Toxicity Following Prostate Radiation Therapy2012
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSAspirin and Statin Nonuse Associated With Early Biochemical Failure After Prostate Radiation2012
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSProstate Bed Motion During Intensity-Modulated Radiotherapy Treatment2012
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSRadiotherapy Treatment Planning for Testicular Seminoma2012
- MEDICAL PHYSICSMagnetic Resonce Spectroscopy of the Prostate: A Phantom Study of Metabolite Concentrations2012
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSEffect of Gold Marker Seeds on Magnetic Resonce Spectroscopy of the Prostate2012
- JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKTesticular Cancer Clinical Practice Guidelines in Oncology2012
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSHypoxic Prostate/Muscle PO2 Ratio Predicts for Outcome in Patients With Localized Prostate Cancer2012
- CANCERLong-Term Survival After Radical Prostatectomy Versus Exterl2011
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSINTENSITY-MODULATED RADIOTHERAPY REDUCES GASTROINTESTIL TOXICITY IN PATIENTS TREATED WITH ANDROGEN2011
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPREDICTORS OF ANDROGEN DEPRIVATION THERAPY EFFICACY COMBINED WITH PROSTATIC IRRADIATION2011
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSThe Impact of Gleason Scoring at a Comprehensive Cancer Center2011
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSA Nomogram Predicting 52011
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSAspirin Use Reduces the Risk of Biochemical Failure2011
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSA Family History of Prostate Cancer is not Associated with Poorer Outcomes following Radiotherapy2011
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSVMAT Reduces Moderate to High Integral Dose When Compared to Conventiol IMRT2011
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIdentification of a Single Nucleotide Polymorphism Related to Late Toxicity in a R2011
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPotential Treatment Margin Reduction for Prostate Treatment with RapidArc and VMAT2011
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSFive Year Results of a R2011
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSGenetic Polymorphisms of D Repair2011
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSProstate Bed Motion during Intensity Modulated Radiotherapy Treatment2011
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSTreatment-related Side Effects And Quality Of Life Among Prostate Cancer Patients Treated With2011
- CADIAN JOURL OF UROLOGYImplantation of electromagnetic transponders following radical prostatectomy for delivery of IMRT2010
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSSTEREOTACTIC BODY RADIOTHERAPY FOR EARLY-STAGE NON-SMALL-CELL LUNG CANCER2010
- TURE REVIEWS CLINICAL ONCOLOGYRADIOTHERAPY PSA dir predicts long-term mortality2010
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSSTEREOTACTIC BODY RADIOTHERAPY FOR PRIMARY MAGEMENT OF EARLY-STAGE2010
- BJU INTERTIOLEvaluation of the Prostate Cancer Prevention Trial Risk calculator in a high2010
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSYoung Age under 60 is not a Contraindication to Treatment with Definitive High Dose Exterl Beam2010
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIntermediate-risk Prostate Cancer Treated with High Dose Radiotherapy Alone or in Combition with2010
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSLow Pretreatment PET SUV Predicts for Incre2010
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSThe Stamp Test Delivers the Message on Erectile Dysfunction following High Dose IMRT2010
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPrelimiry Results of RTOG 02332010
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSA Practical Strategy to Correct Prostate Rotation Reported by a 4D Localization System2010
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSInterval to Biochemical Failure is Highly Prognostic for Distant Metastases2010
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSConventiol versus Hypofractioted IMRT2010
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSThe Role of Adjuvant and Salvage Post-Prostatectomy IMRT or 3DCRT: The Fox Chase Experience2010
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSGAINS FROM REAL-TIME TRACKING OF PROSTATE MOTION DURING EXTERL BEAM RADIATION THERAPY2009
- JOURL OF CLINICAL ONCOLOGYAndrogen Deprivation Therapy and Prostate Cancer Duration2009
- JOURL OF THORACIC ONCOLOGYOptimal PET response following stereotactic body radiotherapy2009
- JOURL OF THORACIC ONCOLOGYFil report of a phase I Dose Escalation Trial of Stereotactic Body Radiotherapy2009
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSRTOG GU RADIATION ONCOLOGY SPECIALISTS REACH CONSENSUS ON PELVIC LYMPH NODE VOLUMES FOR HIGH2009
- JOURL OF CLINICAL ONCOLOGYCorrelation of hypoxic prostate/muscle p(O2) (P/M P-O2) ratio2009
- JOURL OF UROLOGYResidual Prostate Cancer After Radiotherapy2009
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSInitial PSA (iPSA) and Radiation Dose Predict for an Undetectable PSA following 3DCRT or IMRT for2009
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSDefining Biochemical Failure following Salvage Radiotherapy2009
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSA Potential Outcomes Framework to Determine Whether Age2009
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIs MRI-based Week Three Post-implant Dosimetry Necessary following LDR Prostate Brachytherapy?2009
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSValidating the Interval to Biochemical Failure2009
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSUndetectable Post-treatment PSA following 3DCRT or IMRT Alone for Patients with Low or Intermediate2009
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSHypofractiotion for Prostate Cancer: Interim Results of a Randomized Trial2009
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSDOES TREATMENT DURATION AFFECT OUTCOME AFTER RADIOTHERAPY FOR PROSTATE CANCER?2008
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSComment on dose escalation and biochemical failure in prostate cancer2008
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSA comparison of acute2008
- JOURL OF UROLOGYInfluence of local tumor control on distant metastases and cancer related mortality after exterl2008
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSHow can men destined for biochemical failure after androgen deprivation and radiotherapy be2008
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPercentage of biopsy cores positive for maligncy2008
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSCommentary on dose escalation and biochemical failure in prostate cancer2008
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPredicting local persistence of intermediate2008
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSInterval to biochemical failure highly prognostic for distant metastasis2008
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSLow morbidity and excellent local control using image guided stereotactic body radiotherapy2008
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSGains from real-time prostate motion monitoring during exterl beam radiation therapy2008
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSThe optimum duration of combition androgen deprivation therapy2008
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSAndrogen deprivation therapy plus hypofractioted prostate radiotherapy2008
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSRadiation therapy for high risk prostate cancer2008
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSEstimating gains in biochemical outcome from various durations of2008
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPSA doubling time predicts for the development of distant metastases2008
- JOURL OF UROLOGYProstate cancer risk assessment program: A 10-year update of cancer detection2007
- INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSWhat dose of exterl-beam radiation is high enough for prostate cancer?2007
- Journal of clinical oncologyRandomized trial of hypofractionated external-beam radiotherapy for prostate cancer.2013
- LANCET ONCOLOGYTransurethral surgery2013
- JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKGleason Scoring at a Comprehensive Cancer Center: What's The Difference?2013
- CANCERAssessment of the American Joint Committee on Cancer Staging2012
- JOURNAL OF CLINICAL ONCOLOGYValidating the Interval to Biochemical Failure2012
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSRADIOTHERAPY DOSES OF 80 GY AND HIGHER ARE ASSOCIATED WITH LOWER MORTALITY IN MEN WITH GLEASON2012
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSDEVELOPMENT OF RTOG CONSENSUS GUIDELINES FOR THE DEFINITION OF THE CLINICAL TARGET VOLUME FOR2010
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSInflammatory Bowel Disease Is Not an Absolute Contraindication to Definitive Radiation Therapy2013
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSCT-MRI Fusion Uncertainty in Prostate Treatment Planning for Different Image Guidance Techniques2013
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSToxicity and Biochemical Failure Following Image2013
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSImproved Outcomes in Men Treated With Adjuvant or Early Salvage Postprostatectomy IMRT2013
- NATURE REVIEWS UROLOGYStratifying intermediate-risk patients for radiotherapy2013
- PHYSICS IN MEDICINE AND BIOLOGYReduction of prostate intrafractional motion from shortening the treatment time2013
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSA Novel Method for Predicting Late Genitourinary Toxicity After Prostate Radiation Therapy2013
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSUntitled Reply2013
- International journal of radiation oncology, biology, physicsIn reply to Cheung.2013
- CANCERThe impact of dose-escalated radiotherapy plus2013
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSProspective Validation of Diagnostic Tumor Tissue Ki2012
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPrimary Prostate Radiation Therapy: Where Are We Failing?2012
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSDeterminants of Prostate Biopsy Positivity 2 Years After Radiation Therapy2012
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSDo Testosterone Kinetics After Radiation Therapy (RT) Predict Biochemical Failure (BCF) for Low-2012
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSRecursive Partitioning Analysis of Intermediate Risk Prostate Cancer Patients Identifies Subgroup2012
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSA Novel Methodology to Predict Late Urinary Toxicity Following Prostate Radiation Therapy2012
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSAspirin and Statin Nonuse Associated With Early Biochemical Failure After Prostate Radiation2012
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSProstate Bed Motion During Intensity-Modulated Radiotherapy Treatment2012
- UROLOGYStamp Test Delivers Message on Erectile Dysfunction After High-dose Intensity2012
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSRadiotherapy Treatment Planning for Testicular Seminoma2012
- BRACHYTHERAPYA survey of current clinical practice in permanent and temporary prostate brachytherapy2012
- MEDICAL PHYSICSMagnetic Resonance Spectroscopy of the Prostate: A Phantom Study of Metabolite Concentrations2012
- MEDICAL PHYSICSHow Certain Can the Real-Time Plan Predict the Post Dosimetry for Prostate Seed Implant?2012
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSEffect of Gold Marker Seeds on Magnetic Resonance Spectroscopy of the Prostate2012
- BRACHYTHERAPYBiochemical and clinical experience with real2012
- JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKTesticular Cancer Clinical Practice Guidelines in Oncology2012
- RADIOTHERAPY AND ONCOLOGYAn evidence based review of proton beam therapy2012
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSHypoxic Prostate/Muscle PO2 Ratio Predicts for Outcome in Patients2012
- RADIOTHERAPY AND ONCOLOGYYoung age under 60 years is not a contraindication to treatment with definitive dose escalated2011
- CANCERLong-Term Survival After Radical Prostatectomy Versus External2011
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSINTENSITY-MODULATED RADIOTHERAPY REDUCES GASTROINTESTINAL TOXICITY IN PATIENTS TREATED WITH2011
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPREDICTORS OF ANDROGEN DEPRIVATION THERAPY EFFICACY COMBINED WITH PROSTATIC IRRADIATION2011
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSThe Impact of Gleason Scoring at a Comprehensive Cancer Center on the Ability to Predict Recurrence2011
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSA Nomogram Predicting 52011
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSAspirin Use Reduces the Risk of Biochemical Failure2011
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSA Family History of Prostate Cancer is not Associated with Poorer Outcomes following Radiotherapy2011
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSVMAT Reduces Moderate to High Integral Dose When Compared to Conventional IMRT2011
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIdentification of a Single Nucleotide Polymorphism Related to Late Toxicity in a R2011
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPotential Treatment Margin Reduction for Prostate Treatment with RapidArc and VMAT2011
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSFive Year Results of a R2011
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSGenetic Polymorphisms of DNA Repair2011
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSProstate Bed Motion during Intensity Modulated Radiotherapy Treatment2011
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSTreatment-related Side Effects And Quality Of Life Among Prostate Cancer Patients Treated With2011
- CANADIAN JOURNAL OF UROLOGYImplantation of electromagnetic transponders following radical prostatectomy for delivery of IMRT2010
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSSTEREOTACTIC BODY RADIOTHERAPY FOR EARLY-STAGE NON-SMALL-CELL LUNG CANCER2010
- ONCOLOGY-NEW YORKAndrogen Deprivation Therapy in High-Risk Prostate Cancer2010
- NATURE REVIEWS CLINICAL ONCOLOGYRADIOTHERAPY PSA nadir predicts long-term mortality2010
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSSTEREOTACTIC BODY RADIOTHERAPY FOR PRIMARY MANAGEMENT OF EARLY-STAGE2010
- BRACHYTHERAPYAn intraoperative real-time sleeved seed technique for permanent prostate brachytherapy2010
- BJU INTERNATIONALEvaluation of the Prostate Cancer Prevention Trial Risk calculator in a high2010
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSYoung Age under 60 is not a Contraindication to Treatment with Definitive High Dose External Beam2010
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIntermediate-risk Prostate Cancer Treated with High Dose Radiotherapy Alone or in Combination with2010
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSLow Pretreatment PET SUV Predicts for Incre2010
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSThe Stamp Test Delivers the Message on Erectile Dysfunction following High Dose IMRT2010
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPreliminary Results of RTOG 02332010
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSA Practical Strategy to Correct Prostate Rotation Reported by a 4D Localization System2010
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSInterval to Biochemical Failure is Highly Prognostic for Distant Metastases2010
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSConventional versus Hypofractionated IMRT2010
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSThe Role of Adjuvant and Salvage Post-Prostatectomy IMRT or 3DCRT: The Fox Chase Experience2010
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSGAINS FROM REAL-TIME TRACKING OF PROSTATE MOTION DURING EXTERNAL BEAM RADIATION THERAPY2009
- JOURNAL OF CLINICAL ONCOLOGYAndrogen Deprivation Therapy and Prostate Cancer Duration2009
- JOURNAL OF THORACIC ONCOLOGYOptimal PET response following stereotactic body radiotherapy2009
- JOURNAL OF THORACIC ONCOLOGYFinal report of a phase I Dose Escalation Trial of Stereotactic Body Radiotherapy2009
- ONCOLOGY-NEW YORKSurveillance for Stage I Seminoma2009
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSRTOG GU RADIATION ONCOLOGY SPECIALISTS REACH CONSENSUS ON PELVIC LYMPH NODE VOLUMES FOR HIGH2009
- RADIOTHERAPY AND ONCOLOGYDosimetric comparison of stereotactic body radiotherapy using 4D CT2009
- JOURNAL OF CLINICAL ONCOLOGYCorrelation of hypoxic prostate/muscle p(O2) (P/M P-O2) ratio2009
- JOURNAL OF UROLOGYResidual Prostate Cancer After Radiotherapy2009
- CANCER PREVENTION RESEARCHRace, Genetic West African Ancestry2009
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSInitial PSA (iPSA) and Radiation Dose Predict for an Undetectable PSA following 3DCRT or IMRT for2009
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSDefining Biochemical Failure following Salvage Radiotherapy2009
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSA Potential Outcomes Framework to Determine Whether Age2009
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIs MRI-based Week Three Post-implant Dosimetry Necessary following LDR Prostate Brachytherapy?2009
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSValidating the Interval to Biochemical Failure2009
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSUndetectable Post-treatment PSA following 3DCRT or IMRT Alone for Patients with Low or Intermediate2009
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSHypofractionation for Prostate Cancer: Interim Results of a Randomized Trial2009
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSDOES TREATMENT DURATION AFFECT OUTCOME AFTER RADIOTHERAPY FOR PROSTATE CANCER?2008
- UROLOGYResidual prostate cancer after radiotherapy: A study of radical cystoprostatectomy specimens2008
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSComment on dose escalation and biochemical failure in prostate cancer2008
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSA comparison of acute2008
- UROLOGYDoes transurethral resection of prostate2008
- JOURNAL OF UROLOGYInfluence of local tumor control on distant metastases and cancer related mortality after external2008
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSHow can men destined for biochemical failure after androgen deprivation and radiotherapy be2008
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPercentage of biopsy cores positive for malignancy2008
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSCommentary on dose escalation and biochemical failure in prostate cancer2008
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPredicting local persistence of intermediate2008
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSInterval to biochemical failure highly prognostic for distant metastasis2008
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSLow morbidity and excellent local control using image guided stereotactic body radiotherapy2008
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSGains from real-time prostate motion monitoring during external beam radiation therapy2008
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSThe optimum duration of combination androgen deprivation therapy2008
- CANCERThe phoenix definition of biochemical failure predicts for overall survival2008
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSAndrogen deprivation therapy plus hypofractionated prostate radiotherapy2008
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSRadiation therapy for high risk prostate cancer2008
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSEstimating gains in biochemical outcome from various durations of2008
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSPSA doubling time predicts for the development of distant metastases for patients who fail 3DCRT2008
- JOURNAL OF UROLOGYProstate cancer risk assessment program: A 10-year update of cancer detection2007
- CANCERTiming of biochemical failure and distant metastatic disease for low-, intermediate-2007
- INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSWhat dose of external-beam radiation is high enough for prostate cancer?2007
- MEDICAL PHYSICSDaily localization for prostate bed patients based on surgical clips2007
- MEDICAL PHYSICSDosimetric comparison of 4D and 3 multi-phase CT imaging for stereotactic body radiation therapy2007
- MEDICAL PHYSICSSurface smoothing of a tubular structure using a non-shrinking algorithm2007
- Do stranded seeds improve the quality of permanent prostate seed0
Experience & Accolades
- Associate Professor of Radiation Oncology (Radiation Therapy)the Stanford University Medical Center
Dr. Mark K Buyyounouski M.D.'s Practice location
Practice At 333 Cottman Ave Fox Chase Cancer Center
333 Cottman Ave Fox Chase Cancer Cen -Philadelphia, PA 19111Get Direction
Dr. Mark K Buyyounouski M.D.'s reviews
Write ReviewPatient Experience with Dr. Buyyounouski
Recommended Articles
- What Medications Are Used for Prostate Cancer?
Prostate cancer treatments can be administered to cure cancer or to manage or alleviate its symptoms. There are several ways of treating prostate cancer and the treatment options depend on various factors such as:...
- Radiation Therapy vs Chemotherapy
Radiation TherapyIn this method, the doctors will use gamma rays, x-rays, and charged particles that will be directed at, implanted, or introduced directly into the blood stream. In this form of treatment, you will find the three types of therapy that will all be described according to way they...
- Financially Managing Lymphoma Care
If you are living with lymphoma, one of your main concerns may be the payment charges that seem to be piling up too quickly. It can be stressful enough living with cancer, let alone having to worry about going into debt. For this reason, it is important to become aware of the different expenses...
- What Is an X-Ray?
An X-ray is a type of electromagnetic radiation, which can be used to take digital images of parts of the human body. It is the same with visible light but has a certain different characteristic. The beneficial use of an X-ray is for medical imaging. It can help the physician to look inside your...
- Cervical Cancer Defined
The cervix connects the uterus and vagina. The endocervix is the part of the cervix that is closest to the uterus while an ectocervix is nearer to the vagina. Most cases of cervical cancer begin in the cell at the transformation zone. This zone is where the two main types of cells in the cervix...
- Does Bladder Cancer Require Chemotherapy for Treatment?
Does bladder cancer require chemotherapy for treatment?Bladder cancer can be treated through a number of ways and chemotherapy is one of them. Chemotherapy is an important treatment method and it works well in many cases. However, to understand whether it is necessary, it is important to know what...
Nearby Providers
- Dr. Shirnett K. Williamson M.D.446 Bellevue Ave Trenton NJ 08618
- Igor G. Rayevsky1112 Winding Drive Cherry Hill New Jersey 8003
- Dr. Megan A. Mezera MD2 Cooper Plz Camden NJ 08103
- Dr. James David Kolker MD51 N 39th St Philadelphia PA 19104
- Dr. Eric Mark Horwitz M.D.333 Cottman Ave Philadelphia PA 19111
- Dr. Nicole L Simone M.D.111 S. 11th Street Philadelphia PA 19107
Nearest Hospitals
NAZARETH HOSPITALl
2601 HOLME AVE PHILADELPHIA PA 19152CANCER TREATMENT CENTERS OF AMERICAl
1331 EAST WYOMING AVENUE PHILADELPHIA PA 19124STANFORD HEALTH CAREl
300 PASTEUR DRIVE STANFORD CA 94305MENLO PARK SURGICAL HOSPITALl
570 WILLOW ROAD MENLO PARK CA 94025LUCILE SALTER PACKARD CHILDREN'S HSP AT STANFORDl
725 WELCH ROAD PALO ALTO CA 94304